
CNMD · NYSE
CONMED Corporation
$45.85 -0.65 (-1.36%)
Company overview
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Exchange
- NYSE
- Market cap
- $1.4B
- Employees
- 3,900
- Headquarters
- Largo, FL
- Website
- conmed.com
- CEO
- Patrick J. Beyer
- Listed
- July 23, 1987
- P/E
- 25.87
- Dividend yield
- 1.54%
Company financials
- Revenue
- $1.4B
- Gross profit
- $735M
- Operating income
- $153M
- EBITDA
- $211M
- Net income
- $54.8M
- EPS
- $1.77
- Total assets
- $2.3B
- Total debt
- $861M
- Gross margin
- 53.58%
- Net margin
- 4.00%
- Earnings yield
- 3.87%
Showing FY 2025